Analyst Consensus ?
ConsensusHold49 ratings
Bullish2346.9%
Neutral1734.7%
Bearish918.4%
Lennar Corporation · LEN · FY2024 Q4 · Calendar Q4 2024
Lennar shifts toward volume as rates pressure sales and margins
Lennar's asset-light strategy and cost controls provide a potential foundation for longer-term growth, but the current evidence is mixed: higher rates and incentives pressured Q4 performance, guidance was lowered, and execution remains important.
Reported After market closeNYSEConsumer Cyclical
$18.34B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $4.18
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $10.11B
Revenue surprise
—
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-5.2%
Event window
SPY move
-0.0%
Same window
Abnormal move
-5.1%
Stock minus SPY
Volume
2.8×
Versus trailing sessions
Subsequent drift
+1.6%
Up to 20 sessions
LENSPY benchmark
Ask FN2 about LEN FY2024 Q4
Transcript, numbers and history already loaded
What drove LEN's -5.2% move after FY2024 Q4 earnings?What changed in LEN's guidance and outlook in FY2024 Q4?Give me the bull and bear case for LEN after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter's confident, maintained outlook, management's tone became cautious and guidance sentiment was lowered. The focus shifted from strong volume growth toward managing rate-related demand and incentive pressure while executing the Millrose spin-off and Rausch Coleman integration.
Guidance delta
Guidance sentiment was lowered; Q1 2025 guidance was 17–17.5 thousand homes and 19–19.25% margin.
Key takeaways
- Higher rates and increased incentives hurt Q4 sales and gross margin.
- Management continues an asset-light strategy centered on the Millrose spin-off and Rausch Coleman integration.
- The balance sheet remains strong, while Q1 2025 guidance was lowered.
Management priorities
- Advance the Millrose REIT spin-off.
- Integrate Rausch Coleman Homes.
- Protect volume while moderating incentives and continue strengthening cash.
Follow LEN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$77.08Current
$60Low
$119.03Average
$236High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 19, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 7, 2026 |
| Keefe, Bruyette & Woods | Underperform | Underperform | Maintain | Sep 22, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Sep 21, 2026 |
| RBC Capital | Underperform | Underperform | Maintain | Sep 18, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Sep 18, 2026 |
| Barclays | Underweight | Underweight | Maintain | Sep 18, 2026 |
| Citizens | Market Perform | Market Perform | Maintain | Sep 17, 2026 |
| Truist Securities | Hold | Hold | Maintain | Sep 16, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Sep 14, 2026 |
| UBS | Neutral | Neutral | Maintain | Jun 16, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jun 16, 2026 |
| Seaport Global | Sell | Buy | Downgrade | Apr 7, 2026 |
| Wedbush | Neutral | Neutral | Maintain | Sep 22, 2025 |
| Raymond James | Underperform | Market Perform | Downgrade | Sep 22, 2025 |
| JMP Securities | Market Outperform | Market Perform | Upgrade | Sep 22, 2025 |
| Zelman & Assoc | Neutral | Outperform | Downgrade | Jun 18, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Mar 31, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Mar 25, 2025 |
| BTIG | Neutral | Buy | Downgrade | Dec 20, 2024 |
| Argus Research | Buy | Buy | Maintain | Jun 27, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Mar 15, 2024 |
| Deutsche Bank | Sell | Sell | Maintain | Jun 1, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Mar 16, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Dec 16, 2022 |
| Wolfe Research | Outperform | Outperform | Maintain | Mar 16, 2021 |
| Susquehanna | Positive | Neutral | Upgrade | Sep 17, 2020 |
| CFRA | Hold | Hold | Maintain | May 11, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Oct 3, 2019 |
| Buckingham | Buy | Buy | Maintain | Oct 3, 2019 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Aug 13, 2019 |
| Bank of America | Buy | Buy | Maintain | Jun 26, 2019 |
| Argus | Buy | Buy | Maintain | Oct 15, 2018 |
| Maxim Group | Buy | Buy | Maintain | May 23, 2018 |
| Mizuho | Buy | Neutral | Upgrade | Jan 18, 2018 |
| MKM Partners | Buy | Neutral | Upgrade | Oct 4, 2017 |
| BTIG Research | Buy | Buy | Maintain | Oct 4, 2017 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Sep 21, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Jan 19, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Jan 19, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Sep 22, 2015 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 15, 2015 |
| Compass Point | Neutral | Neutral | Maintain | Oct 13, 2014 |
| CRT Capital | Buy | Hold | Upgrade | Jun 27, 2013 |
| FBN Securities | Sector Perform | Underperform | Upgrade | Apr 3, 2013 |
| Williams Capital | Buy | Buy | Maintain | Jan 16, 2013 |
| Topeka | Hold | Hold | Maintain | Dec 7, 2012 |
| ISI Group | Buy | Buy | Maintain | Sep 25, 2012 |
| Williams Financial | Buy | Buy | Maintain | May 17, 2012 |
| Guggenheim | Neutral | Neutral | Maintain | Mar 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $77.08. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $75 | $77.41 | -2.7% | Oct 7, 2026 |
| Morgan Stanley | Analyst unavailable | $65 | $81.59 | -15.7% | Oct 1, 2026 |
| RBC Capital | Mike Dahl | $69 | $75.96 | -10.5% | Sep 18, 2026 |
| BTIG | Ryan Gilbert | $63 | $79.7 | -18.3% | Sep 18, 2026 |
| Barclays | Analyst unavailable | $70 | $79.7 | -9.2% | Sep 18, 2026 |
| Truist Financial | Jonathan Bettenhausen | $75 | $80.07 | -2.7% | Sep 16, 2026 |
| Wells Fargo | Sam Reid | $80 | $77.9 | +3.8% | Sep 11, 2026 |
| Truist Financial | Jonathan Bettenhausen | $80 | $86.24 | +3.8% | Aug 6, 2026 |
| Argus Research | Christopher Graja | $108 | $84.76 | +40.1% | Jul 9, 2026 |
| UBS | John Lovallo | $94 | $89.75 | +22.0% | Jun 16, 2026 |
| RBC Capital | Analyst unavailable | $85 | $91.91 | +10.3% | Jun 15, 2026 |
| BTIG | Analyst unavailable | $67 | $90.3 | -13.1% | Jun 15, 2026 |
| Wells Fargo | Analyst unavailable | $85 | $90.3 | +10.3% | Jun 15, 2026 |
| Barclays | Analyst unavailable | $79 | $90.3 | +2.5% | Jun 15, 2026 |
| BTIG | Analyst unavailable | $73 | $90.49 | -5.3% | Jun 8, 2026 |
| Goldman Sachs | Analyst unavailable | $125 | $120.9 | +62.2% | Jan 13, 2026 |
| RBC Capital | Analyst unavailable | $88 | $109.55 | +14.2% | Jan 9, 2026 |
| UBS | John Lovallo | $122 | $105.4 | +58.3% | Jan 6, 2026 |
| UBS | John Lovallo | $137 | $109.32 | +77.7% | Dec 18, 2025 |
| Goldman Sachs | Susan Maklari | $120 | $112.23 | +55.7% | Dec 18, 2025 |
| BTIG | Analyst unavailable | $90 | $112.23 | +16.8% | Dec 18, 2025 |
| Wells Fargo | Analyst unavailable | $110 | $112.23 | +42.7% | Dec 18, 2025 |
| Barclays | Matthew Bouley | $88 | $112.23 | +14.2% | Dec 18, 2025 |
| Evercore ISI | Analyst unavailable | $92 | $112.23 | +19.4% | Dec 18, 2025 |
| RBC Capital | Analyst unavailable | $95 | $112.23 | +23.2% | Dec 17, 2025 |
| Barclays | Matthew Bouley | $98 | $123.91 | +27.1% | Dec 8, 2025 |
| Evercore ISI | Analyst unavailable | $114 | $126.39 | +47.9% | Oct 7, 2025 |
| JMP Securities | Aaron Hecht | $140 | $127.32 | +81.6% | Sep 22, 2025 |
| Wells Fargo | Analyst unavailable | $135 | $132.68 | +75.1% | Sep 2, 2025 |
| Barclays | Analyst unavailable | $110 | $117.56 | +42.7% | Mar 24, 2025 |
| Wells Fargo | Sam Reid | $190 | $182.25 | +146.5% | Oct 7, 2024 |
| Evercore ISI | Stephen Kim | $236 | $185.8 | +206.2% | Sep 24, 2024 |
| Bank of America Securities | Rafe Jadrosich | $190 | $185.3 | +146.5% | Sep 23, 2024 |
| Citigroup | Anthony Pettinari | $196 | $184.62 | +154.3% | Sep 23, 2024 |
| BTIG | Carl Reichardt | $216 | $182.19 | +180.2% | Sep 23, 2024 |
| RBC Capital | Mike Dahl | $160 | $184.87 | +107.6% | Sep 23, 2024 |
| Goldman Sachs | Susan Maklari | $190 | $182.19 | +146.5% | Sep 23, 2024 |
| Goldman Sachs | Susan Maklari | $182 | $192.45 | +136.1% | Sep 20, 2024 |
| Wells Fargo | Sam Reid | $205 | $179.42 | +166.0% | Sep 9, 2024 |
| Goldman Sachs | Susan Maklari | $174 | $170.94 | +125.7% | Jul 22, 2024 |
| RBC Capital | Mike Dahl | $145 | $148.72 | +88.1% | Jun 20, 2024 |
| Goldman Sachs | Susan Maklari | $180 | $148.72 | +133.5% | Jun 20, 2024 |
| Evercore ISI | Stephen Kim | $237 | $148.72 | +207.5% | Jun 20, 2024 |
| Barclays | Matthew Bouley | $177 | $148.72 | +129.6% | Jun 20, 2024 |
| Citigroup | Anthony Pettinari | $183 | $153.06 | +137.4% | Jun 14, 2024 |
| Wedbush | Jay McCanless | $144 | $153.95 | +86.8% | Jun 10, 2024 |
| Argus Research | Chris Graja | $175 | $160.27 | +127.0% | Apr 11, 2024 |
| Jefferies | Collin Verron | $144 | $156.57 | +86.8% | Mar 15, 2024 |
| UBS | John Lovallo | $198 | $156.57 | +156.9% | Mar 15, 2024 |
| Wells Fargo | Deepa Raghavan | $175 | $156.57 | +127.0% | Mar 15, 2024 |
| Evercore ISI | Stephen Kim | $238 | $156.57 | +208.8% | Mar 15, 2024 |
| Raymond James | Buck Horne | $165 | $148.23 | +114.1% | Dec 19, 2023 |
| Raymond James | Buck Horne | $150 | $115.97 | +94.6% | Sep 14, 2023 |
| Deutsche Bank | Nishu Sood | $105 | $116.46 | +36.2% | Jun 13, 2023 |
| Citigroup | Anthony Pettinari | $113 | $98.96 | +46.6% | Mar 14, 2023 |
| RBC Capital | Analyst unavailable | $79 | $93.18 | +2.5% | Dec 16, 2022 |
| J.P. Morgan | Analyst unavailable | $97 | $84.26 | +25.8% | Nov 22, 2022 |
| JMP Securities | Aaron Hecht | $115 | $80.5 | +49.2% | Oct 4, 2022 |
| Barclays | Matthew Bouley | $85 | $69.64 | +10.3% | Jun 29, 2022 |
| Wedbush | Jay McCanless | $88 | $69.48 | +14.2% | Jun 29, 2022 |
| Raymond James | Buck Horne | $75 | $69.64 | -2.7% | Jun 29, 2022 |
| Evercore ISI | Stephen Kim | $112 | $69.64 | +45.3% | Jun 29, 2022 |
| UBS | John Lovallo | $108 | $69.64 | +40.1% | Jun 29, 2022 |
| KeyBanc | Kenneth Zener | $60 | $69.64 | -22.2% | Jun 29, 2022 |
| BTIG | Carl Reichardt | $97 | $72.04 | +25.8% | Jun 28, 2022 |
| UBS | John Lovallo | $154 | $82.51 | +99.8% | Mar 28, 2022 |
| BTIG | Carl Reichardt | $118 | $88.22 | +53.1% | Mar 21, 2022 |
| KeyBanc | Kenneth Zener | $75 | $86.27 | -2.7% | Mar 15, 2022 |
| Goldman Sachs | Susan Maklari | $140 | $92.02 | +81.6% | Feb 16, 2022 |
| KeyBanc | Kenneth Zener | $86 | $96.86 | +11.6% | Jan 19, 2022 |
| Seaport Global | Mark Weintraub | $133 | $107.74 | +72.5% | Jan 14, 2022 |
| Raymond James | Buck Horne | $125 | $108.3 | +62.2% | Dec 21, 2021 |
| Argus Research | Chris Graja | $120 | $105.4 | +55.7% | Dec 20, 2021 |
| JMP Securities | Aaron Hecht | $130 | $105.43 | +68.7% | Dec 17, 2021 |
| Wedbush | Jay McCanless | $130 | $105.43 | +68.7% | Dec 17, 2021 |
Track every rating change on LEN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationLennar Corporation, an influential homebuilder in the United States, operates primarily under its widely recognized Lennar brand, alongside its various subsidiaries. The company structures its diverse business initiatives across several distinct divisions: regional homebuilding segments (East, Central, Texas, and West), a Financial Services arm, a Multifamily property development unit, and a broader "Lennar Other" category. At the heart of its operations, Lennar is deeply involved in the creation and sale of single-family homes, encompassing both attached and detached designs.…
Historical context
All LEN earningsLatest beats and misses
Who reports nextBeat on EPS
Get the LEN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-12-10T21:40:51.092160+00:00
- Polygon adjusted daily market bars · 2026-10-19T01:10:43.095170+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-19T01:10:43.092328+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-19. For educational purposes only; not investment advice.